Jilifen Recombinant Human

Jilifen is indicated for neutropenia inducted by anti-cancer chemotherapy and various other causes. For patients receiving myelosuppressive cheomtherapy especically intensive, myeloablative chemotherapy, Jilifen injection can prevent neutropenia and accelerate the recovery of neutrophils. As a result,the risk of complication with infection is decreased.Dosage form: ampoule/ Pre-filled syringe.Specification: 75ug,150ug,300ug. product offered by Hangzhou Jiuyuan Gene Engineering Co., Ltd.